Study of 18F-DCFPyL, a Second Generation Low-molecular Weight PSMA-based PET Radiotracer, in Patients With Prostate Cancer
Status:
Completed
Trial end date:
2020-04-01
Target enrollment:
Participant gender:
Summary
This study is being done to determine the safety, biodistribution, and radiation dosimetry of
18F-DCFPyL, and to detect prostate cancer by visual analysis.
Phase:
Phase 1
Details
Lead Sponsor:
Sidney Kimmel Comprehensive Cancer Center Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins